Uniunea Europeană - română - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanomul - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

swords laboratories unlimited company - irlanda - combinatii (nivolumabum+relatlimabum) - conc. pt. sol. perf. - 240mg/80mg - alte antineoplazice alte antineoplazice in combinatie